Home
Conditions
Uterine Leiomyosarcoma

Clinical trial condition

Uterine Leiomyosarcoma

Explore clinical trials studying Uterine Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

11 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Uterine Leiomyosarcoma trial results

Recruiting

Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS

NCT07076186

Conditions: Uterine Leiomyosarcoma
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Letrozole in Uterine Leiomyosarcoma

NCT05649956

Conditions: Uterine Leiomyosarcoma
Locations: University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

Highlands Ranch Hospital Highlands Ranch, Colorado, United States

Broward Health Medical Center Fort Lauderdale, Florida, United States

Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States

View all 34 locations

View Trial Details

Recruiting

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

NCT07467772

Conditions: Adenosarcoma of the uterus, ESS, Endometrial Neoplasms, +25 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids

NCT06244251

Conditions: Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: West China Second University Hospital Chengdu, Sichuan, China

View Trial Details

Completed

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

NCT04727242

Conditions: LMS - Leiomyosarcoma, Uterine Leiomyosarcoma
Locations: Stanford University Stanford, California, United States

View Trial Details

Completed

Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS

NCT06678763

Conditions: Uterine Leiomyosarcoma
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

NCT00378911

Conditions: Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00659360

Conditions: Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, +41 more
Locations: Fox Chase Cancer Center Rockledge, Pennsylvania, United States

Cross Cancer Institute Edmonton, Alberta, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

Montreal General Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

NCT00614835

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

NCT00390234

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +30 more
Locations: City of Hope Duarte, California, United States

University of Southern California Los Angeles, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View all 16 locations

View Trial Details

Uterine Leiomyosarcoma

Uterine Leiomyosarcoma trial results

Related conditions